Drug-Loaded Colloidal Systems in Nanomedicine II
This reprint highlights high-quality original research and review papers that include innovative colloidal drug delivery systems and cutting-edge characterization techniques that significantly contribute to the area of nanomedicine. The results presented are of high interest for specialists from a b...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_93242 | ||
| 005 | 20221025 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20221025s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-5359-7 | ||
| 020 | |a 9783036553603 | ||
| 020 | |a 9783036553597 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-5359-7 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 072 | 7 | |a TDCB |2 bicssc | |
| 100 | 1 | |a Atanase, Leonard |4 edt | |
| 700 | 1 | |a Atanase, Leonard |4 oth | |
| 245 | 1 | 0 | |a Drug-Loaded Colloidal Systems in Nanomedicine II |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (234 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This reprint highlights high-quality original research and review papers that include innovative colloidal drug delivery systems and cutting-edge characterization techniques that significantly contribute to the area of nanomedicine. The results presented are of high interest for specialists from a broad spectrum of fields, including biomedical, pharmaceutical, industrial, and biotechnological spheres. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 650 | 7 | |a Chemical engineering |2 bicssc | |
| 653 | |a synthetic antimicrobial polymers | ||
| 653 | |a assembled nanostructures | ||
| 653 | |a surfaces and coatings | ||
| 653 | |a antimicrobial properties | ||
| 653 | |a folate-targeted nanoparticles | ||
| 653 | |a BSA/alginate nanocarriers | ||
| 653 | |a paclitaxel | ||
| 653 | |a cellular uptake | ||
| 653 | |a cell viability | ||
| 653 | |a ciprofibrate | ||
| 653 | |a drug delivery | ||
| 653 | |a Rietveld method | ||
| 653 | |a crystallography | ||
| 653 | |a nanotechnology | ||
| 653 | |a neuropathy | ||
| 653 | |a polymeric nanoparticles | ||
| 653 | |a preclinical investigation | ||
| 653 | |a pharmacokinetics of pregabalin | ||
| 653 | |a antinociceptive effect | ||
| 653 | |a induced sleep | ||
| 653 | |a polymer nanoparticles | ||
| 653 | |a glioma/glioblastoma | ||
| 653 | |a blood-brain barrier (BBB)/blood brain tumour barrier (BBTB) | ||
| 653 | |a nanodiagnostics | ||
| 653 | |a drug delivery and imaging | ||
| 653 | |a nanocrystals | ||
| 653 | |a surface modification | ||
| 653 | |a chemotherapy | ||
| 653 | |a cancer | ||
| 653 | |a cyclosporine A | ||
| 653 | |a ethoxylated fatty acid | ||
| 653 | |a block copolymer | ||
| 653 | |a polymeric micelles | ||
| 653 | |a ocular | ||
| 653 | |a nanoparticles | ||
| 653 | |a natural and synthetic polymers | ||
| 653 | |a drug delivery systems | ||
| 653 | |a biocompatibility | ||
| 653 | |a in vivo tests | ||
| 653 | |a nicarbazin | ||
| 653 | |a DNC | ||
| 653 | |a glycyrrhizic acid | ||
| 653 | |a PVP | ||
| 653 | |a micelles | ||
| 653 | |a coccidiosis | ||
| 653 | |a Pluronic | ||
| 653 | |a F127 | ||
| 653 | |a drug delivery system | ||
| 653 | |a active pharmaceutical ingredient | ||
| 653 | |a antimicrobial activity | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6140 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/93242 |7 0 |z DOAB: description of the publication |